Gastrodin ameliorates depression-like behaviors and up-regulates proliferation of hippocampal-derived neural stem cells in rats: Involvement of its anti-inflammatory action

Behavioural Brain Research

Volumn 266, Issue , 2014, Pages 153-160

  Wang, Huaning ^a   Zhang, Ruiguo ^a   Qiao, Yuting ^a,b   Xue, Fen ^a   Nie, Huang ^a   Zhang, Zhangjin ^c   Wang, Ying ^a   Peng, Zhengwu ^a,b   Tan, Qingrong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic unpredictable stress; Depression; Gastrodin; Hippocampal stem cell; IL 1 ; Inflammation

Indexed keywords

ANTIDEPRESSANT AGENT; GASTRODIN; I KAPPA B KINASE BETA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; NEUROPROTECTIVE AGENT; BENZYL ALCOHOL DERIVATIVE; GLUCOSIDE; SUCROSE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BRDU ASSAY; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SOLUBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED SWIM TEST; HIPPOCAMPUS; HOPELESSNESS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LOW DRUG DOSE; MALE; MORRIS WATER MAZE TEST; MOTOR RETARDATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; STRESS; SUCROSE PREFERENCE TEST; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL SURVIVAL; COMPLICATION; CYTOLOGY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FOOD PREFERENCE; MAZE TEST; MENTAL STRESS; PSYCHOLOGY; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZYL ALCOHOLS; CELL SURVIVAL; CELLS, CULTURED; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FOOD PREFERENCES; GLUCOSIDES; HIPPOCAMPUS; MALE; MAZE LEARNING; NEURAL STEM CELLS; RATS; STRESS, PSYCHOLOGICAL; SUCROSE; SWIMMING; UP-REGULATION;

EID: 84897823777     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.02.046     Document Type: Article

References (50)

1. Al-Harbi K.S. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence 2012, 6:369-388.
2. Pae C.U., Patkar A.A. Clinical issues in use of atypical antipsychotics for depressed patients. CNS Drugs 2013, 27(Suppl. 1):S39-S45.
3. Schosser A., Serretti A., Souery D., Mendlewicz J., Zohar J., Montgomery S., et al. European Group for the Study of Resistant Depression (GSRD)-where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmacol 2012, 22:453-468.
4. Jain F.A., Hunter A.M., Brooks J.O., Leuchter A.F. Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety 2013, 30:624-630.
5. Minichino A., Bersani F.S., Capra E., Pannese R., Bonanno C., Salviati M., et al. ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review. Neuropsychiatr Dis Treat 2012, 8:55-64.
6. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996, 29:2-11.
7. Willner P., Scheel-Kruger J., Belzung C. The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 2012.
8. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
9. Duman R.S., Aghajanian G.K. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012, 338:68-72.
10. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
11. Zunszain P.A., Hepgul N., Pariante C.M. Inflammation and depression. Curr Top Behav Neurosci 2013, 14:135-151.
12. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:664-675.
13. Hocaoglu C., Kural B., Aliyazicioglu R., Deger O., Cengiz S. IL-1beta, IL-6, IL-8, IL-10, IFN-gamma, TNF-alpha and its relationship with lipid parameters in patients with major depression. Metab Brain Dis 2012, 27:425-430.
14. Maes M., Twisk F.N., Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom 2012, 81:286-295.
15. Koo J.W., Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 2008, 105:751-756.
16. Hsieh M.T., Wu C.R., Chen C.F. Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol 1997, 56:45-54.
17. Kim H.J., Lee S.R., Moon K.D. Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils. Phytother Res 2003, 17:909-912.
18. Kim H.J., Moon K.D., Lee D.S., Lee S.H. Ethyl ether fraction of Gastrodia elata Blume protects amyloid beta peptide-induced cell death. J Ethnopharmacol 2003, 84:95-98.
19. Kim H.J., Moon K.D., Oh S.Y., Kim S.P., Lee S.R. Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus. Neurosci Lett 2001, 314:65-68.
20. Dai J.N., Zong Y., Zhong L.M., Li Y.M., Zhang W., Bian L.G., et al. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One 2011, 6:e21891.
21. Zhang R., Peng Z., Wang H., Xue F., Chen Y., Wang Y., et al. Gastrodin ameliorates depressive-like behaviors and up-regulates the expression of BDNF in the hippocampus and hippocampal-derived astrocyte of rats. Neurochem Res 2014, 39:172-179.
22. Peng Z., Wang H., Zhang R., Chen Y., Xue F., Nie H., et al. Gastrodin ameliorates anxiety-like behaviors and inhibits IL-1beta level and p38 MAPK phosphorylation of hippocampus in the rat model of posttraumatic stress disorder. Physiol Res 2013, 62:537-545.
23. Campbell S., MacQueen G. An update on regional brain volume differences associated with mood disorders. Curr Opin Psychiatry 2006, 19:25-33.
24. Stockmeier C.A., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004, 56:640-650.
25. Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: a road to remission. Science 2012, 338:72-75.
26. Banasr M., Valentine G.W., Li X.Y., Gourley S.L., Taylor J.R., Duman R.S. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 2007, 62:496-504.
27. Yang P., Han Y., Gui L., Sun J., Chen Y.L., Song R., et al. Gastrodin attenuation of the inflammatory response in H9c2 cardiomyocytes involves inhibition of NF-kappaB and MAPKs activation via the phosphatidylinositol 3-kinase signaling. Biochem Pharmacol 2013, 85:1124-1133.
28. Shu G., Yang T., Wang C., Su H., Xiang M. Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-kappaB signaling activation in CD4+ T cells. Toxicol Appl Pharmacol 2013, 269:270-279.
29. Wang Y., Cui X.L., Liu Y.F., Gao F., Wei D., Li X.W., et al. LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1831-1835.
30. Slattery D.A., Cryan J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 2012, 7:1009-1014.
31. Feng S.F., Shi T.Y., Fan Y., Wang W.N., Chen Y.C., Tan Q.R. Long-lasting effects of chronic rTMS to treat chronic rodent model of depression. Behav Brain Res 2012, 232:245-251.
32. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
33. Peng Z., Zhang R., Wang H., Chen Y., Xue F., Wang L., et al. Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells. Behav Brain Res 2013, 244:1-8.
34. Ojemann L.M., Nelson W.L., Shin D.S., Rowe A.O., Buchanan R.A. Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilepsy Behav 2006, 8:376-383.
35. Park S., Kim da S., Kang S. Gastrodia elata Blume water extracts improve insulin resistance by decreasing body fat in diet-induced obese rats: vanillin and 4-hydroxybenzaldehyde are the bioactive candidates. Eur J Nutr 2011, 50:107-118.
36. Zeng X., Zhang S., Zhang L., Zhang K., Zheng X. A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro. Planta Med 2006, 72:1359-1365.
37. Xu X., Lu Y., Bie X. Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons. Planta Med 2007, 73:650-654.
38. Hill M.N., Hellemans K.G., Verma P., Gorzalka B.B., Weinberg J. Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 2012, 36:2085-2117.
39. Hollis F., Isgor C., Kabbaj M. The consequences of adolescent chronic unpredictable stress exposure on brain and behavior. Neuroscience 2013, 249:232-241.
40. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
41. Jun H., Mohammed Qasim Hussaini S., Rigby M.J., Jang M.H. Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders. Neural Plast 2012, 2012:854285.
42. Lee M.M., Reif A., Schmitt A.G. Major depression: a role for hippocampal neurogenesis. Curr Top Behav Neurosci 2013, 14:153-179.
43. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
44. Timmermans W., Xiong H., Hoogenraad C.C., Krugers H.J. Stress and excitatory synapses: From health to disease. Neuroscience 2013, 248:626-636.
45. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
46. Sapolsky R.M. Is impaired neurogenesis relevant to the affective symptoms of depression. Biol Psychiatry 2004, 56:137-139.
47. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:676-692.
48. Song C., Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:760-768.
49. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:730-743.
50. Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci U S A 2010, 107:2669-2674.